Cite
APA Citation
Ma, B. B. Y., Chan, S. L., Ho, W. M., Lau, W., Mo, F., Hui, E. P., Chan, C., Poon, A., Dattatray, R. D., Wong, S. C. C., To, K. F., King, A. D., Ahuja, A., & Chan, A. T. C. (2013). intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first‐line treatment of metastatic colorectal cancer. Cancer, 119(23), 4145–4153. http://access.bl.uk/ark:/81055/vdc_100025044095.0x000025